Side effects, such as an increased risk of fungal infections and of tuberculosis for the patients with latent Mycobacterium tuberculosis infections, are escalated after anti-TNF-α therapy [43], or some patients poorly respond to this therapy. The gene discussed is TNF; the disease is fungal infectious disease.